Olena Lavoshnyk, Gennady Georgievsky, Valerii Shapovalov
The article is devoted to the analysis of corruption manifestations in the field of health care in Ukraine from the standpoint of medical and pharmaceutical law, as well as the experience of the United States of America within the framework of the program "America is Back", aimed at strengthening the patient-oriented approach. Modern trends in reforming the US health care system, mechanisms for preventing fraud, abuse and misuse of funds in medical institutions are considered. A comparative analysis of the practices of the United States and Ukraine regarding fight against corruption in the field of medicine, specific examples from forensic pharmaceutical practice are given, which demonstrate the systemic nature of problems in the domestic health care system. The role of the National Health Service of Ukraine, the Ministry of Health, the State Audit Service and law enforcement agencies in identifying violations, abuses and misuse of budget funds is shown. The need to improve the skills of medical and pharmaceutical workers in the field of medical and pharmaceutical law, to ensure the transparency of financial transactions and to strengthen the personal responsibility of the heads of medical institutions has been substantiated. It is proposed to introduce effective mechanisms of control, unification of the regulatory framework and monitoring to minimize corruption risks and build citizens' trust in the medical system of Ukraine.